Cambridge, MA, United States of America

James Stefater

This inventor holds 1 USPTO granted patent. Top assignee: Eyecool Therapeutics, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by James Stefater in Ocular Surface Discomfort

Introduction

James Stefater is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of ocular health through his innovative solutions aimed at alleviating symptoms of ocular surface discomfort. His work is particularly relevant for individuals suffering from various eye-related issues.

Latest Patents

James Stefater holds a patent for "Formulations, devices, and methods for alleviating symptoms of ocular surface discomfort." This patent discloses cold slurry formulations that include ice and a freezing temperature depressant, with optional lipids. The formulations are designed to alleviate discomfort on the ocular surface. The patent also details devices and methods that protect the target ocular surface from direct contact with the cold slurry, ensuring that the temperature is maintained for optimal relief. Additionally, self-contained devices are described, which are configured to receive the cold slurry formulation. These innovations aim to protect the cornea and eyelid from the freezing effects of the slurry, enhancing the overall treatment experience.

Career Highlights

James Stefater is associated with Eyecool Therapeutics, Inc., where he continues to develop and refine his innovative solutions for ocular health. His work has the potential to significantly improve the quality of life for individuals experiencing ocular discomfort.

Collaborations

James collaborates with Charles Sidoti, leveraging their combined expertise to advance the field of ocular therapeutics.

Conclusion

James Stefater's innovative contributions to ocular health through his patented formulations and devices represent a significant advancement in the treatment of ocular surface discomfort. His work continues to pave the way for improved therapeutic options in this important area of health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…